VarCov Co’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,547
Closed -$1.03M – 387
2026
Q2
$1.03M Buy
+4,547
New +$810K 0.39% 89
2026
Q1
– Sell
-1,774
Closed -$354K – 425
2025
Q4
$354K Buy
+1,774
New +$322K 0.14% 251

Other funds holding CRL

VarCov Co's CRL Position: Q3 2026 in Review

VarCov Co sold out of Charles River Laboratories (CRL) in Q3 2026, closing a stake of 4,547 shares — an estimated $1.03M sold.

VarCov Co first reported a position in CRL in Q4 2025 and held it in 2 quarters. The position peaked at $1.03M in Q2 2026. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • VarCov Co reported no remaining Charles River Laboratories position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 4,547 Charles River Laboratories shares in Q3 2026, an estimated $1.03M.
  • VarCov Co first reported a position in Charles River Laboratories in Q4 2025 and held it in 2 quarters.
  • VarCov Co's Charles River Laboratories position peaked at $1.03M in Q2 2026.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.